Regardless, at the doses investigated and using intravitreal injection methods, NLRP3 inhibition did not appear to reduce photoreceptor cell death, inflammation or improve retinal function following photo-oxidative damage, suggesting that targeting NLRP3 may not slow the progression of retinal degenerations. Here, NLRP3 is linked to retinal degeneration.